Technanogy

Technanogy was a nanotechnology-focused incubator and venture capital firm founded in 2000 and headquartered in Newport Beach, California. The company specialized in identifying, funding, and commercializing nanotechnology applications, with a primary focus on the life sciences, materials, and electronics industries. In the healthcare sector, Technanogy operated through several subsidiaries, most notably Angstrom Pharmaceuticals, which developed peptide-based therapeutics for cancer, and Nanostream, which focused on microfluidic diagnostic systems. The firm's strategy involved licensing intellectual property from academic institutions and developing it into market-ready technologies. Although it was a prominent entity during the early nanotechnology investment boom, Technanogy is no longer active.